Stay updated on Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record history shows a newer revision label (v3.6.2) replacing the old v3.6.0. This indicates the page version was updated in the history tracking.
    Difference
    0.1%
    Check dated 2026-06-29T08:37:00.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate no longer looking for participants. The record revision is updated to v3.6.0, replacing the previous v3.5.5 entry.
    Difference
    0.3%
    Check dated 2026-06-15T08:20:09.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A new revision entry v3.5.5 was added to the study history, and the previous revision v3.5.4 was removed.
    Difference
    0.1%
    Check dated 2026-06-08T03:44:16.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now displays the current site revision as v3.5.4, replacing the previous v3.5.3. This indicates a minor UI/backend update and does not modify the study record content or its results.
    Difference
    0.1%
    Check dated 2026-05-17T10:00:51.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Record history now displays the study as Completed with updated Study Status, Recruitment Status, and Contacts/Locations, replacing the previous Active, not recruiting label. New version/date entries accompany the update.
    Difference
    0.6%
    Check dated 2026-05-10T08:30:06.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    This updates the ClinicalTrials.gov interface version label from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a UI/release revision rather than a change to the trial record itself.
    Difference
    0.1%
    Check dated 2026-04-25T18:37:37.000Z thumbnail image

Stay in the know with updates to Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page.